GBIO Insider Trading Activity and SEC Form 4 Filings
GBIO insider trading summary
No open-market insider purchases or sales of Generation Bio Co. (GBIO) have been reported on SEC Form 4 in the past 12 months.
Latest GBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 13, 2025 | Anthony G. Quinn | Insider | Buy | $82K (85,000 @ $0.97) |
| Jan 10, 2025 | Anthony G. Quinn | Insider | Buy | $121K (125,791 @ $0.96) |
| Jul 1, 2024 | Antoinette Paone | Chief Operating Officer | Sell | $18K (6,719 @ $2.74) |
| Jan 2, 2024 | Antoinette Paone | Chief Operating Officer | Sell | $4K (2,445 @ $1.62) |
| Jan 2, 2024 | Phillip Samayoa | Chief Strategy Officer | Sell | $4K (2,445 @ $1.62) |
| Dec 8, 2023 | Dannielle Appelhans | Insider | Buy | $1K (637 @ $1.82) |
| Dec 8, 2023 | Dannielle Appelhans | Insider | Buy | $13K (7,363 @ $1.79) |
| Dec 4, 2023 | Charles A Rowland Jr | Insider | Buy | $225K (150,000 @ $1.50) |
| Dec 4, 2023 | Dannielle Appelhans | Insider | Buy | $18K (12,000 @ $1.50) |
| Dec 1, 2023 | Donald William Nicholson | Insider | Buy | $144K (100,000 @ $1.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.